SRC and neoplasm: On average, we observed a significant inhibition of phosphorylation of Src at Tyr416 (Fig. 7b) in animals harbouring tumours treated with JVG045 compared to control (vehicle) treated tumours (two-samples t-test on normalised data t(14.97) = 2.207, p = 0.0434).